Skip to main content
OpenTrials

Clinical trial condition

Porphyrias, Hepatic

Explore clinical trials studying Porphyrias, Hepatic. Study availability and eligibility vary by location and protocol.

47 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Porphyrias, Hepatic trial results

Completed

Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP

NCT05308472

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +10 more
Locations
  • University of Alabama Hospital Birmingham, Alabama, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria

NCT03520036

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria (EPP), +10 more
Locations
  • ACTCA, A Member of the Alliance, Inc. Los Angeles, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Metro Boston Clinical Partners, LLC Brighton, Massachusetts, United States
View Trial Details
Completed

ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)

NCT03338816

Conditions
ALA Dehydratase Deficient Porphyria (ADP), Acute Hepatic Porphyria, Acute Intermittent Porphyria, +17 more
Locations
  • Clinical Trial Site Little Rock, Arkansas, United States
  • Clinical Trial Site San Francisco, California, United States
  • Clinical Trial Site Boston, Massachusetts, United States
  • Clinical Trial Site Ann Arbor, Michigan, United States
View all 36 locations
View Trial Details
Completed

A Study to Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)

NCT02949830

Conditions
Acute Intermittent Porphyria, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +10 more
Locations
  • Clinical Trial Site San Francisco, California, United States
  • Clinical Trial Site New York, United States
  • Clinical Trial Site Galveston, Texas, United States
  • Clinical Trial Site Stockholm, Sweden
View Trial Details
Completed

Harvoni Treatment Porphyria Cutanea Tarda

NCT03118674

Conditions
Blood-Borne Infections, Communicable Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
  • University of Texas Medical Branch Galveston, Texas, United States
View Trial Details
Completed

Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)

NCT00979745

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +10 more
Locations
  • HUS:n Iho-ja allergiasairaala (Skin and Allergy Hospital) Helsinki, Finland
  • Centre Français des Porphyries, Hôpital Louis Mourier Colombes, Cedex, France
  • Department of Dermatology , Heinrich-Heine-University Duesseldorf Düsseldorf, Germany
  • Beaumont Hospital, Department of Dermatology Dublin, Ireland
View Trial Details

Related conditions